Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.03M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.42x
$23.18Latest market snapshot
Implied fair value · at NE's multiple
$68.58195.9% above market
2.03 AMPH EPS (TTM)×33.79x NE P/E=$68.58
Market $23.18Implied $68.58
NE · current priceP/E 33.79x
$45.61Latest market snapshot
Implied fair value · at AMPH's multiple
$15.4266.2% below market
1.35 NE EPS (TTM)×11.42x AMPH P/E=$15.42
Market $45.61Implied $15.42